Arkolith/Insider Trading/DNLI/Form 4

Watts Ryan J.

President and CEO, DirectorDenali Therapeutics Inc. (DNLI) · full profile →Form 4 · filed Jul 11, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7.4M
Net Open-Market Flow
-$7.4M
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 9, 2025Option exercise(M)40K$5.28$211K748K
Jul 9, 2025Sell(S)495K$15.00$7.4M253K
Jul 9, 2025Option exercise(M)455K$0.68$310K708K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 9, 2025Option exercise(M)455K—$0623K
Jul 9, 2025Option exercise(M)40K—$020K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001714899-25-000149) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML